Donna Ryan, MD
President, World Obesity Federation
Pennington Biomedical Research Center
Baton Rouge, LA
Christopher D. Still, DO, FACN, FACP, FTOS
Professor of Medicine
Department of Clinical Science
Geisinger Commonwealth School of Medicine
Medical Director, Center for Nutrition and Weight Management
Director, Geisinger Obesity Institute
Geisinger Health System
Erin Mooney, MS
Clinical Content Manager
Rebecca L. Julian, MS, ELS
Senior Manager, Editorial
Samantha Gordon, MS
Director of CME
Intended Learning Outcomes
Upon completion, participants should be able to:
This activity is intended for primary care clinicians.
Statement of Need
Obesity is now understood to be a complex, chronic disease, but enduring misperceptions and stigmatizations about this condition still exist among the general population and healthcare professionals. Numerous patient-, provider-, and system-based barriers contribute to the challenge of addressing obesity in the clinical environment and contribute to poor outcomes in affected patients. Only a small minority of patients with obesity receive comprehensive, guideline-recommended treatment that includes the options of behavioral, lifestyle, pharmacologic, and/or surgical care. Evidence from Med-IQ's social media obesity education campaign “Obesity: Breaking Through the Barriers of a Misunderstood Chronic Condition” in 2019 uncovered a critical ongoing need to educate providers on a broader approach to obesity management and help them lead more effective and supportive discussions with patients.
Provided by Med-IQ.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Medium/Method of Participation
This is a 0.75-credit CME activity. To receive credit, read the introductory CME material, complete all of the modules, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 26, 2020
Expiration Date: October 25, 2021
Estimated Time to Complete This Activity: 45 minutes
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Donna Ryan, MD
Consulting fees/advisory boards: Boehringer Ingelheim Pharmaceuticals, Inc., Epitomee Medical, Janssen Pharmaceuticals, Inc., Novo Nordisk, Redesign Health, Sanofi-aventis U.S. Inc.
Fees received for promotional/non-CME activities: Bausch Health, Novo Nordisk
Ownership interest (stocks/stock options – excluding mutual funds): Epitomee Medical, Gila Therapeutics, Phenomix Sciences, Inc., Redesign Health, Scientific Intake, Xeno Biosciences
Christopher D. Still, DO, FACN, FACP, FTOS
Consulting fees/advisory boards: Ethicon, Novo Nordisk
Fees received for promotional/non-CME activities: Novo Nordisk
Contracted research: Ethicon
The writer, peer reviewers, and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email firstname.lastname@example.org.
Applications & Software
For technical assistance, please refer to our Support Manual.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Novo Nordisk, Inc.
© 2020 Med-IQ, Inc.
Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available at the "Continue" button below.
Obesity is now recognized as a chronic disease and is defined by the World Health Organization as an abnormal or excessive fat accumulation that presents a health risk to an individual. Obesity is associated with a number of related health effects and sequelae, including cardiovascular disease and type 2 diabetes mellitus. The pathophysiology underlying obesity also provides biological pathways for resistance to long-term weight loss. This reality puts primary care providers on the front lines with patients to take part in discussions about the long-term health effects of obesity and, more importantly, the realignment of strategies that may be necessary to manage weight. Due to the individual and cultural stigma that surrounds obesity, discussions with patients about weight must convey willingness for an ongoing partnership and a lack of judgment. Key considerations include:
Click “Continue” to proceed through this activity and receive credit, or select a specific module from the menu on the left.